Map of India’s bulk drug and formulation facilities

By Nick Taylor

- Last updated on GMT

Related tags Param name= Pharmacology Drug Pharmaceutical drug

in-PharmaTechnologist presents exclusive interactive maps of pharma manufacturing facilities in India, detailing the number of bulk drug and formulation facilities in each region of the country.

India has grown into a major player in the pharma manufacturing sector and the scale and distribution of operations can be seen on the maps below. The maps were put together using 2007 data from the Directory of Pharmaceutical Manufacturing Units in India​.

Note – since publication some people have questioned the accuracy of the Indian National Pharmaceutical Pricing Authority (NPPA) data used in the visualisations (see comment section). in-PharmaTechnologist is currently investigating the accuracy of the data.

Update 2nd June 2010 - the NPPA is in the process of finalising a new census of the Indian pharma industry. in-PharmaTechnologist plans to publish a new map when this becomes available.

Maharashtra is clearly the dominant force in both formulation and bulk drugs which is in keeping with its position as India’s leading industrial estate. Gujarat trails Maharashtra in both bulk drug and formulation but beyond this the situation is more varied.

For example, West Bengal has the third most formulation facilities, 694, but relatively few bulk drugs sites, with seven states having more of these plants. This is visualised on the chart below.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...